Human Blood Cells Reprogrammed Into Neural Stem Cells Shed Decades of Epigenetic Age
Converting blood cells directly into neural stem cells triggers dramatic epigenetic de-aging, resetting biological age to as little as 5% of donor age.
Summary
Researchers converted blood-derived erythroid progenitor cells from donors ranging from newborns to 101 years old into induced neural stem cells using SOX2 and cMYC, without passing through pluripotency. An epigenetic clock showed that cells from aged donors retained around 13% of the original donor age at low passages and 5% at high passages. De-aging continued for several weeks, even under proliferation-inhibiting conditions. Gene-expression differences between young- and old-donor-derived cells also faded over time. Acquisition of a bona fide neural stem cell signature extended well beyond the emergence of proliferating PAX6-positive cells. Established lines lacked age-associated cellular hallmarks, similar to induced pluripotent stem cells and their derivatives. The system offers a model for studying epigenetic de-aging, although clock age is not a direct measure of cellular function.
Detailed Summary
Cell reprogramming can affect epigenetic age differently depending on the route taken. Reprogramming to induced pluripotent stem cells (iPSCs) can reset DNA methylation age to an embryonic level, whereas direct conversion into post-mitotic neurons can preserve the source cells' DNA methylation age. This study examined how epigenetic age and cell identity change during direct conversion into proliferating induced neural stem cells (iNSCs).
The researchers used blood-derived erythroid progenitor cells from donors ranging from newborns to 101 years old. They generated iNSCs through Sendai virus-mediated overexpression of SOX2 and cMYC, without passing through a pluripotent stage. They also generated isogenic pairs of iNSCs and iPSC-derived neural stem cells. DNA methylation and RNA sequencing analyses tracked the conversion process, with epigenetic de-aging defined using the clock published by Horvath and colleagues in 2018.
The central result was pronounced epigenetic de-aging in iNSCs from aged donors. Their clock-estimated ages corresponded to around 13% of the original donor age at low passages and 5% at high passages. De-aging was protracted, continuing for several weeks and even under proliferation-inhibiting conditions. The supplied excerpt does not identify the agents or timing used to inhibit proliferation. Gene-expression differences between young- and old-donor-derived iNSCs also dissipated with extended time in conversion.
Established iNSC lines lacked age-associated cellular hallmarks, similar to iPSCs and their derivatives. Time-course DNA methylation and RNA sequencing data showed that acquisition of a bona fide neural stem cell signature extended well beyond the emergence of proliferating PAX6-positive cells. Thus, early marker expression did not indicate that cell-fate consolidation was complete.
The slow dynamics make this conversion system useful for studying transdifferentiation and epigenetic de-aging. However, DNA methylation age is a proxy for biological age, not a direct measurement of age-related cellular function. The provided evidence concerns cultured-cell conversion and does not establish organismal rejuvenation or clinical transplant safety.
Key Findings
- Blood-derived erythroid progenitor cells from donors ranging from newborns to 101 years old were converted into iNSCs using SOX2 and cMYC, without passing through pluripotency
- iNSCs from aged donors retained clock-estimated ages corresponding to around 13% of the original donor age at low passages and 5% at high passages
- Epigenetic de-aging was protracted, continuing for several weeks during conversion
- De-aging continued under proliferation-inhibiting conditions; the supplied excerpt does not specify the agents or treatment timing
- Transcriptomic differences between young- and old-donor-derived iNSCs dissipated with longer time in conversion
- Established iNSC lines lacked age-associated cellular hallmarks, similar to iPSCs and their derivatives
- Acquisition of a bona fide neural stem cell signature extended well beyond the emergence of proliferating PAX6-positive cells
Methodology
Blood-derived erythroid progenitor cells were converted into iNSCs using Sendai virus-mediated SOX2 and cMYC overexpression. The researchers generated isogenic pairs of iNSCs and iPSC-derived neural stem cells from donors spanning newborns to 101 years old. DNA methylation and RNA sequencing analyses tracked conversion over time, and epigenetic age was assessed using the clock published by Horvath and colleagues in 2018. The excerpt reports continued de-aging under proliferation-inhibiting conditions but does not specify those interventions, the methylation platform, the RNA sequencing format, or the statistical analysis details.
Study Limitations
DNA methylation age is a proxy for biological age, not a direct measure of age-related cellular function. The provided excerpt describes cultured-cell experiments and reports no organismal rejuvenation results. Because the supplied text is truncated, the total donor count, per-group sample sizes, detailed statistical methods, specific proliferation-inhibiting treatments, and conflict-of-interest statements could not be verified.
Enjoyed this summary?
Get the latest longevity research delivered to your inbox every week.
Enter your email to subscribe:
